Our API Delivery Technology Sends 300% More Cannabinoids Into The Human Bloodstream: Lexaria Bioscience Corp

Our drug delivery technology prevents people from overdosing on edibles: Chris Bunka, CEO, Lexaria Bioscience Corp (CSE: LLX)

At the New Green Frontier Cannabis Investor Conference, we caught up with Chris Bunka, the Chairman and CEO of Lexaria Bioscience Corp (CSE: LLX), which he describes as an intellectual property company servicing the cannabis industry. He explains that Lexaria has invented a faster and a more effective way to deliver active pharmaceutical ingredients (API) into the bloodstream. Chris Bunka also explains developing cannabis infused beverages without the aroma and taste of the plant.

To read our full disclosure, please click on the button below: